ANS Parasympathetic Drugs Flashcards
1
Q
Describe Pilocarpine
A
- Name: Pilocarpine
- MOA: muscarinic agonist
- Therapeutic uses: Glaucoma
- S/E: blurred vision, painful eye, night blindness and headache
- Administration: topical (opthalmic)
2
Q
Neostigmine
A
- Neostigmine
- Reversible Ach-E inhibitor
- To reverse neuromuscular blocker effects/ myasthenia gravis
- Cholinergic crisis ( give atropine/ glycopyrolate)
- IM, SC or IV
3
Q
Pyridostigmine
A
- Pyridostigmine
- Reversible Ach-E inhibitor
- Chronic myasthenia gravis
- Cholinergic crisis
- Oral
4
Q
Physostigmine
A
- Physostigmine
- Reversible Ach-E inhibitors
- Increased intestinal and bladder motility
- Convulsions, bradycardia, decreased cardiac output, paralysis of skeletal muscle
5.
5
Q
Edrophonium
A
- Edrophonium
- Reversible Ach-E inhibitor
- To diagnose myasthenia gravis
- Cholinergic crisis
6
Q
Tacrine, donepezil and rivastigmine
A
- Tacrine, rivastigmine and donepezil
- Reversible Ach-E inhibitors
- Alzheimers disease
- Tacrine hepatotoxicity, GI distress
7
Q
Describe the PK of atropine?
A
- Short half life (4hrs); except eye >72 hours
- High affinity for muscarinic receptors, binds competitively (reversible)
- Tissues most sensitive to atropine include: bronchial, salivary and sweat glands
8
Q
What are the therapeutic uses of atropine? 5
A
- In ophthalmology: refractive errors. To produce mydriasis and cycloplegia prior to refraction
- Antispasmodic: to treat spastic disorders of the GI and lower UTI
- Anti-secretory: to suppress respiratory secretions prior to surgery
- Cardiovascular: bradycardia
- Antidote for organophosphate poisoning and mushroom poisoning
9
Q
Describe atropine in general
A
- Atropine
- Muscarinic anatagonis
- Opthamology, antispasmodics of GI and lower UTI, reduce bronchiopulmonary secretions prior to surgery, brachycardia, organophosphate poisoning
- Dry mouth, blurred vision, sandy eyes, tachycardia, urinary retention and constipation
10
Q
Describe scopolamine
A
- Scopolamine
- Muscarinic antagonist: motion sickness, anti nausea
- Motion sickness, reduces vertigo and reduces post op nausea
- Marked CNS effects: xerostomia, sedation and delirium
- Motion sickness: transdermal patch, post op IM
11
Q
Describe hyoscine and dicyclomine
A
- Hyoscine and dicyclomine
- Muscarinic antagonist: ibs, antispasmodic
- Reduces smooth muscle and secretory activity of the gut
- Tachycardia, confusion, urinary retention, intraocular pressure
- Oral and parenteral
12
Q
Describe ipratopium, bromide and tiotropium
A
- Ipratopium, bromide and tiotrpium
- Muscarinic antagonist: Asthma COPD
- Relaxes bronchial smooth muscle
- Xerostomia, cough
- Inhaler
13
Q
Describe glycopyrrolate
A
- Glycopyrrolate
- Muscarinic antagonist: sialorrhea/ diminished salivary secretions
- Decrease salivary and bronchial secretions
- IV
14
Q
Describe ophthalmology atropine
A
- Atropine (opthalmic)
- Muscarinic antagonist: retinal exams
- Mydriasis and cyclop
- Increased intraocular pressure
- Eye drops
15
Q
Describe tropicamide and cyclopentolate
A
- Tropicamide and cyclopentolate
- Muscarinic antagonist: produce mydriasis and cycloplegia prior to refraction
- Mydriasis and cycloplegia
- Eye drops, tropicamide (short acting), cyclopentolate (long acting)